{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:47:36Z","timestamp":1782179256812,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bagui Young Top Talents Training Project of Guangxi Zhuang Autonomous Region","award":["2023"],"award-info":[{"award-number":["2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13480-7","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:08:28Z","timestamp":1777554508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Explainable prediction of MDR\/RR-TB in tuberculosis-diabetes mellitus multimorbidity: a machine learning model developed and validated in a dual-center study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xinxin","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiujin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingrou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"1","key":"13480_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41572-022-00376-4","volume":"8","author":"ST Skou","year":"2022","unstructured":"Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, Boyd CM, Pati S, Mtenga S, Smith SM. Multimorbidity. Nat Rev Dis Primers. 2022;8(1):48.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"13480_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12762","volume":"152","author":"P Kumar Nathella","year":"2017","unstructured":"Kumar Nathella P, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13\u201324.","journal-title":"Immunology"},{"issue":"2","key":"13480_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.clnu.2020.08.040","volume":"40","author":"Q Wang","year":"2021","unstructured":"Wang Q, Ma A, Schouten EG, Kok FJ. A double burden of tuberculosis and diabetes mellitus and the possible role of vitamin D deficiency. Clin Nutr. 2021;40(2):350\u20137.","journal-title":"Clin Nutr"},{"key":"13480_CR4","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo - Pereira M, Vinhaes CL, et al. Intersecting epidemics: deciphering the complexities of tuberculosis - diabetes comorbidity. Front Tuber. 2024;2.","DOI":"10.3389\/ftubr.2024.1487793"},{"issue":"1","key":"13480_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13098-021-00743-3","volume":"13","author":"M Li","year":"2021","unstructured":"Li M, Chen T, Hua Z, Yan H, Wang D, Li Z, Kang Y, Zhu N, Li C. Global, regional, and national prevalence of diabetes mellitus in patients with pulmonary tuberculosis: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):127.","journal-title":"Diabetol Metab Syndr"},{"key":"13480_CR6","doi-asserted-by":"publisher","first-page":"1122255","DOI":"10.3389\/fimmu.2023.1122255","volume":"14","author":"P Ssekamatte","year":"2023","unstructured":"Ssekamatte P, Sande OJ, van Crevel R, Biraro IA. Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility. Front Immunol. 2023;14:1122255.","journal-title":"Front Immunol"},{"key":"13480_CR7","doi-asserted-by":"crossref","unstructured":"Shankaregowda R, Allegretti YH, Sumana MN, Rao MR, Raphael E, Mahesh PA, Riley LW. Whole-genome sequencing of mycobacterium tuberculosis isolates from diabetic and non-diabetic patients with pulmonary tuberculosis. Microorganisms 2023;11(8).","DOI":"10.3390\/microorganisms11081881"},{"issue":"2","key":"13480_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1590\/s1806-37562017000000443","volume":"44","author":"DR Silva","year":"2018","unstructured":"Silva DR, Mu\u00f1oz-Torrico M, Duarte R, Galv\u00e3o T, Bonini EH, Arbex FF, Arbex MA, Augusto VM, Rabahi MF. Mello FCdQ: Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol. 2018;44(2):145\u201352.","journal-title":"J Bras Pneumol"},{"key":"13480_CR9","unstructured":"World Health Organization. Global Tuberculosis Report 2020. Geneva, Switzerland World Health Organization; 2020."},{"issue":"1","key":"13480_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41598-017-01213-5","volume":"7","author":"Q Liu","year":"2017","unstructured":"Liu Q, Li W, Xue M, Chen Y, Du X, Wang C, Han L, Tang Y, Feng Y, Tao C, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Rep. 2017;7(1):1090.","journal-title":"Sci Rep"},{"key":"13480_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12879-015-1204-5","volume":"15","author":"S Mehta","year":"2015","unstructured":"Mehta S, Yu EA, Ahamed SF, Bonam W, Kenneth J. Rifampin resistance and diabetes mellitus in a cross-sectional study of adult patients in rural South India. BMC Infect Dis. 2015;15:451.","journal-title":"BMC Infect Dis"},{"key":"13480_CR12","doi-asserted-by":"publisher","first-page":"1244450","DOI":"10.3389\/fpubh.2023.1244450","volume":"11","author":"AU Rehman","year":"2023","unstructured":"Rehman AU, Khattak M, Mushtaq U, Latif M, Ahmad I, Rasool MF, Shakeel S, Hayat K, Hussain R, Alhazmi GA, et al. The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TB-diabetes comorbid patients: a systematic review and meta-analysis. Front Public Health. 2023;11:1244450.","journal-title":"Front Public Health"},{"issue":"11\u201312","key":"13480_CR13","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1080\/00365540802342372","volume":"40","author":"SP Fisher-Hoch","year":"2008","unstructured":"Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, Restrepo BI. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis. 2008;40(11\u201312):888\u201393.","journal-title":"Scand J Infect Dis"},{"issue":"7","key":"13480_CR14","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1086\/507543","volume":"43","author":"HMJ Nijland","year":"2006","unstructured":"Nijland HMJ, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RHH, van der Ven AJAM, Danusantoso H, Aarnoutse RE, van Crevel R. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2006;43(7):848\u201354.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"5","key":"13480_CR15","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1016\/S1470-2045(19)30149-4","volume":"20","author":"KY Ngiam","year":"2019","unstructured":"Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262\u201373.","journal-title":"Lancet Oncol"},{"issue":"19","key":"13480_CR16","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/ajhp\/zxaa218","volume":"77","author":"SD Nelson","year":"2020","unstructured":"Nelson SD, Walsh CG, Olsen CA, McLaughlin AJ, LeGrand JR, Schutz N, Lasko TA. Demystifying artificial intelligence in pharmacy. Am J Health Syst Pharm. 2020;77(19):1556\u201370.","journal-title":"Am J Health Syst Pharm"},{"issue":"7","key":"13480_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-019-0193-3","volume":"16","author":"SL Goldenberg","year":"2019","unstructured":"Goldenberg SL, Nir G, Salcudean SE. A new era: artificial intelligence and machine learning in prostate cancer. Nat Rev Urol. 2019;16(7):391\u2013403.","journal-title":"Nat Rev Urol"},{"issue":"5","key":"13480_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","volume":"1","author":"C Rudin","year":"2019","unstructured":"Rudin C. Stop Explaining Black Box Machine Learning Models for High Stakes Decisions and Use Interpretable Models Instead. Nat Mach Intell. 2019;1(5):206\u201315.","journal-title":"Nat Mach Intell"},{"key":"13480_CR19","first-page":"813","volume":"2021","author":"S Lu","year":"2021","unstructured":"Lu S, Chen R, Wei W, Belovsky M, Lu X. Understanding Heart Failure Patients EHR Clinical Features via SHAP Interpretation of Tree-Based Machine Learning Model Predictions. AMIA Annu Symp Proc. 2021;2021:813\u201322.","journal-title":"AMIA Annu Symp Proc"},{"key":"13480_CR20","volume-title":"WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis. Geneva: World Health Organization; 2021."},{"key":"13480_CR21","doi-asserted-by":"publisher","DOI":"10.2471\/B09127","volume-title":"WHO operational handbook on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection (Web Annex C)[R\/OL]","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. WHO operational handbook on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection (Web Annex C)[R\/OL]. 3rd ed. Geneva: WHO; 2024.","edition":"3"},{"key":"13480_CR22","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment. Geneva:World Health Organization; 2022."},{"key":"13480_CR23","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: Treatment - Drug-susceptible tuberculosis treatment. Geneva:World Health Organization; 2021."},{"key":"13480_CR24","unstructured":"World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva:World Health Organization; 2019."},{"issue":"1","key":"13480_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44\u20137.","journal-title":"Value Health"},{"issue":"23","key":"13480_CR26","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1001\/jama.2018.19271","volume":"320","author":"V Kini","year":"2018","unstructured":"Kini V, Ho PM. Interventions to Improve Medication Adherence: A Review. JAMA. 2018;320(23):2461\u201373.","journal-title":"JAMA"},{"key":"13480_CR27","volume-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","author":"World Health Organization, International Diabetes Federation","year":"2006","unstructured":"World Health Organization, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation. Geneva: World Health Organization; 2006."},{"key":"13480_CR28","unstructured":"World Health Organization. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. WHO; 2024."},{"key":"13480_CR29","doi-asserted-by":"publisher","first-page":"102627","DOI":"10.1016\/j.eclinm.2024.102627","volume":"72","author":"A Di Castelnuovo","year":"2024","unstructured":"Di Castelnuovo A, Bonaccio M, Costanzo S, De Curtis A, Magnacca S, Persichillo M, Panzera T, Bracone F, Pignatelli P, Carnevale R, et al. The association between hypoalbuminemia and risk of death due to cancer and vascular disease in individuals aged 65 years and older: findings from the prospective Moli-sani cohort study. EClinicalMedicine. 2024;72:102627.","journal-title":"EClinicalMedicine"},{"key":"13480_CR30","doi-asserted-by":"crossref","unstructured":"Huang L-Y, Chen F-Y, Jhou M-J, Kuo C-H, Wu C-Z, Lu C-H, Chen Y-L, Pei D, Cheng Y-F, Lu C-J. Comparing multiple linear regression and machine learning in predicting diabetic urine albumin-creatinine ratio in a 4-year follow-up study. J Clin Med. 2022;11(13).","DOI":"10.3390\/jcm11133661"},{"issue":"11","key":"13480_CR31","doi-asserted-by":"publisher","first-page":"101073","DOI":"10.1016\/j.patter.2024.101073","volume":"5","author":"C Bunkhumpornpat","year":"2024","unstructured":"Bunkhumpornpat C, Boonchieng E, Chouvatut V, Lipsky D. FLEX-SMOTE: Synthetic over-sampling technique that flexibly adjusts to different minority class distributions. Patterns (N Y). 2024;5(11):101073.","journal-title":"Patterns (N Y)"},{"issue":"1","key":"13480_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12888-025-07763-7","volume":"26","author":"Z Wang","year":"2026","unstructured":"Wang Z, Xu Q, Yu S, Sun J, Lv J, Huang Q, Huang C, Sun Y. Association of depressive symptoms with systemic immune-inflammation index and platelet parameters among survivors of myocardial infarction: a cross-sectional NHANES study enhanced by machine learning and SHAP analysis. BMC Psychiatry. 2026;26(1):148.","journal-title":"BMC Psychiatry"},{"key":"13480_CR33","volume-title":"International Union Against Tuberculosis and Lung Disease. Collaborative framework for care and control of tuberculosis and diabetes[R]","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. International Union Against Tuberculosis and Lung Disease. Collaborative framework for care and control of tuberculosis and diabetes[R]. Geneva: WHO; 2011."},{"key":"13480_CR34","volume-title":"Global Tuberculosis Report 2025 [R]","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Global Tuberculosis Report 2025 [R]. Geneva: WHO; 2025."},{"key":"13480_CR35","first-page":"107140","volume":"146","author":"AA Boadu","year":"2024","unstructured":"Boadu AA, Yeboah-Manu M, Osei-Wusu S, Yeboah-Manu D. Tuberculosis and diabetes mellitus: The complexity of the comorbid interactions. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2024;146:107140.","journal-title":"Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis"},{"issue":"7","key":"13480_CR36","doi-asserted-by":"publisher","first-page":"e1184","DOI":"10.1016\/S2214-109X(24)00148-7","volume":"12","author":"T Broger","year":"2024","unstructured":"Broger T, Marx FM, Theron G, Marais BJ, Nicol MP, Kerkhoff AD, Nathavitharana R, Huerga H, Gupta-Wright A, Kohli M, et al. Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research. Lancet Glob Health. 2024;12(7):e1184\u201391.","journal-title":"Lancet Glob Health"},{"key":"13480_CR37","volume-title":"WHO standard: universal access to rapid tuberculosis diagnostics[R]","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. WHO standard: universal access to rapid tuberculosis diagnostics[R]. Geneva: WHO; 2023."},{"key":"13480_CR38","doi-asserted-by":"publisher","first-page":"103803","DOI":"10.1016\/j.eclinm.2026.103803","volume":"93","author":"UP Gujral","year":"2026","unstructured":"Gujral UP, Huangfu P, Kisho AA, Limb ES, Kamasa-Quashie D, Houndjahoue F, Ogunyemi K, Singh N, Castro KG, White MS, et al. Diabetes screening among people with tuberculosis: a systematic review and meta analysis. EClinicalMedicine. 2026;93:103803.","journal-title":"EClinicalMedicine"},{"issue":"Pt 2","key":"13480_CR39","first-page":"108705","volume":"120","author":"AT Subalakshmi","year":"2025","unstructured":"Subalakshmi AT, Mahesh A. Machine learning approaches to predict drug resistance in tuberculosis. Comput Biol Chem. 2025;120(Pt 2):108705.","journal-title":"Comput Biol Chem"},{"issue":"1","key":"13480_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00330-022-08997-9","volume":"33","author":"Y Li","year":"2023","unstructured":"Li Y, Wang B, Wen L, Li H, He F, Wu J, Gao S, Hou D. Machine learning and radiomics for the prediction of multidrug resistance in cavitary pulmonary tuberculosis: a multicentre study. Eur Radiol. 2023;33(1):391\u2013400.","journal-title":"Eur Radiol"},{"key":"13480_CR41","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3389\/fgene.2019.00922","volume":"10","author":"W Deelder","year":"2019","unstructured":"Deelder W, Christakoudi S, Phelan J, Benavente ED, Campino S, McNerney R, Palla L, Clark TG. Machine Learning Predicts Accurately Mycobacterium tuberculosis Drug Resistance From Whole Genome Sequencing Data. Front Genet. 2019;10:922.","journal-title":"Front Genet"},{"issue":"1","key":"13480_CR42","doi-asserted-by":"publisher","first-page":"102332","DOI":"10.1016\/j.bjid.2022.102332","volume":"26","author":"A Sharma","year":"2022","unstructured":"Sharma A, Machado E, Lima KVB, Suffys PN, Concei\u00e7\u00e3o EC. Tuberculosis drug resistance profiling based on machine learning: A literature review. Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis. 2022;26(1):102332.","journal-title":"Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis"},{"issue":"1","key":"13480_CR43","doi-asserted-by":"publisher","first-page":"13619","DOI":"10.1038\/s41598-025-96973-w","volume":"15","author":"MS Rahman","year":"2025","unstructured":"Rahman MS, Shiddik AB. Utilizing artificial intelligence to predict and analyze socioeconomic, environmental, and healthcare factors driving tuberculosis globally. Sci Rep. 2025;15(1):13619.","journal-title":"Sci Rep"},{"issue":"4","key":"13480_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10096-008-0627-y","volume":"28","author":"I Su\u00e1rez-Garc\u00eda","year":"2009","unstructured":"Su\u00e1rez-Garc\u00eda I, Rodr\u00edguez-Blanco A, Vidal-P\u00e9rez JL, Garc\u00eda-Viejo MA, Jaras-Hern\u00e1ndez MJ, L\u00f3pez O, Noguerado-Asensio A. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol. 2009;28(4):325\u201330.","journal-title":"Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol"},{"issue":"6","key":"13480_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0929-6646(11)60055-7","volume":"110","author":"J-T Chang","year":"2011","unstructured":"Chang J-T, Dou H-Y, Yen C-L, Wu Y-H, Huang R-M, Lin H-J, Su I-J, Shieh C-C. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Association = Taiwan Yi Zhi. 2011;110(6):372\u201381.","journal-title":"J Formos Med Association = Taiwan Yi Zhi"},{"issue":"3","key":"13480_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3201\/eid2103.141343","volume":"21","author":"G G\u00fcnther","year":"2015","unstructured":"G\u00fcnther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, et al. Multidrug-resistant tuberculosis in Europe, 2010\u20132011. Emerg Infect Dis. 2015;21(3):409\u201316.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"13480_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/thx.2005.045963","volume":"61","author":"A Faustini","year":"2006","unstructured":"Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158\u201363.","journal-title":"Thorax"},{"issue":"4","key":"13480_CR48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10096-024-04779-x","volume":"43","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liu J, Zhang Q, Chen H, Chai L, Wang Y, Zhang J, Qiu Y, Shen N, Shi X, et al. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol. 2024;43(4):747\u201365.","journal-title":"Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol"},{"issue":"6","key":"13480_CR49","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","volume":"77","author":"IS Pradipta","year":"2018","unstructured":"Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar J-W. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis. J Infect. 2018;77(6):469\u201378.","journal-title":"J Infect"},{"key":"13480_CR50","doi-asserted-by":"publisher","first-page":"1516207","DOI":"10.3389\/fmed.2025.1516207","volume":"12","author":"L Wu","year":"2025","unstructured":"Wu L, Chen N, Xia D, Jiang X. Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus. Front Med. 2025;12:1516207.","journal-title":"Front Med"},{"issue":"1","key":"13480_CR51","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12879-019-4014-3","volume":"19","author":"D Okethwangu","year":"2019","unstructured":"Okethwangu D, Birungi D, Biribawa C, Kwesiga B, Turyahabwe S, Ario AR, Zhu B-P. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013\u20132017. BMC Infect Dis. 2019;19(1):387.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"13480_CR52","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/trstmh\/trac054","volume":"116","author":"OA Adejumo","year":"2022","unstructured":"Adejumo OA, Daniel O, Adepoju VA, Onoh MO, Sokoya OD, Abdur-Razzaq H, Moronfolu O, Oyadotun OM, Olusola-Faleye B. Pretreatment attrition and treatment initiation delay among rifampicin-resistant tuberculosis patients in Lagos, Nigeria: a retrospective cohort study. Trans R Soc Trop Med Hyg. 2022;116(12):1154\u201361.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"13480_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4269\/ajtmh.18-0001","volume":"99","author":"SE Saqib","year":"2018","unstructured":"Saqib SE, Ahmad MM, Amezcua-Prieto C, Virginia M-R. Treatment Delay among Pulmonary Tuberculosis Patients within the Pakistan National Tuberculosis Control Program. Am J Trop Med Hyg. 2018;99(1):143\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"13480_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/inthealth\/ihz036","volume":"12","author":"Q Yang","year":"2020","unstructured":"Yang Q, Tong Y, Yin X, Qiu L, Sun N, Zhao Y, Li D, Li X, Gong Y. Delays in care seeking, diagnosis and treatment of patients with pulmonary tuberculosis in Hubei, China. Int Health. 2020;12(2):101\u20136.","journal-title":"Int Health"},{"issue":"1","key":"13480_CR55","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1186\/s12889-025-23288-w","volume":"25","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li Z, Liu L, Chen J, Li L, Yang R, Yang X, Chen L, Ru H, Xu L. Healthcare-seeking pathway and delay analysis of rifampicin-resistant tuberculosis patient in Southwestern China. BMC Public Health. 2025;25(1):2019.","journal-title":"BMC Public Health"},{"key":"13480_CR56","doi-asserted-by":"crossref","unstructured":"Soedarsono S, Mertaniasih NM, Kusmiati T, Permatasari A, Ilahi WK, Anggraeni AT. Characteristics of previous tuberculosis treatment history in patients with treatment failure and the impact on acquired drug-resistant tuberculosis. Antibiot (Basel Switzerland). 2023;12(3).","DOI":"10.3390\/antibiotics12030598"},{"issue":"1","key":"13480_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12879-017-2323-y","volume":"17","author":"S Eshetie","year":"2017","unstructured":"Eshetie S, Gizachew M, Dagnew M, Kumera G, Woldie H, Ambaw F, Tessema B, Moges F. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis. 2017;17(1):219.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"13480_CR58","doi-asserted-by":"publisher","first-page":"e1002595","DOI":"10.1371\/journal.pmed.1002595","volume":"15","author":"N Alipanah","year":"2018","unstructured":"Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7):e1002595.","journal-title":"PLoS Med"},{"issue":"1","key":"13480_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41043-017-0132-y","volume":"37","author":"FH Gebreweld","year":"2018","unstructured":"Gebreweld FH, Kifle MM, Gebremicheal FE, Simel LL, Gezae MM, Ghebreyesus SS, Mengsteab YT, Wahd NG. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Health Popul Nutr. 2018;37(1):1.","journal-title":"J Health Popul Nutr"},{"issue":"5","key":"13480_CR60","doi-asserted-by":"publisher","first-page":"e0155147","DOI":"10.1371\/journal.pone.0155147","volume":"11","author":"HH Tola","year":"2016","unstructured":"Tola HH, Shojaeizadeh D, Tol A, Garmaroudi G, Yekaninejad MS, Kebede A, Ejeta LT, Kassa D, Klinkenberg E. Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial. PLoS ONE. 2016;11(5):e0155147.","journal-title":"PLoS ONE"},{"issue":"1","key":"13480_CR61","doi-asserted-by":"publisher","first-page":"2496405","DOI":"10.1080\/07853890.2025.2496405","volume":"57","author":"B Chen","year":"2025","unstructured":"Chen B, Li Y, Peng Y, Zhou L, Chen X-Y, Ren Y-L, Luo D, Ling Y-X, Zhou Y-Q, Jiang J-M, et al. Care-seeking and treatment pathways of multidrug-resistant tuberculosis patients: an analysis of real-world data from regional health information system in Ningbo City in Eastern China. Ann Med. 2025;57(1):2496405.","journal-title":"Ann Med"},{"issue":"3","key":"13480_CR62","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1002\/mco2.487","volume":"5","author":"S Liang","year":"2024","unstructured":"Liang S, Xu X, Yang Z, Du Q, Zhou L, Shao J, Guo J, Ying B, Li W, Wang C. Deep learning for precise diagnosis and subtype triage of drug-resistant tuberculosis on chest computed tomography. MedComm (2020). 2024;5(3):e487.","journal-title":"MedComm (2020)"},{"issue":"6","key":"13480_CR63","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","volume":"20","author":"ME Urbanowski","year":"2020","unstructured":"Urbanowski ME, Ordonez AA, Ruiz-Bedoya CA, Jain SK, Bishai WR. Cavitary tuberculosis: the gateway of disease transmission. Lancet Infect Dis. 2020;20(6):e117\u201328.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"13480_CR64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.clnu.2023.01.016","volume":"42","author":"J Ockenga","year":"2023","unstructured":"Ockenga J, Fuhse K, Chatterjee S, Malykh R, Rippin H, Pirlich M, Yedilbayev A, Wickramasinghe K, Barazzoni R. Tuberculosis and malnutrition: The European perspective. Clin Nutr. 2023;42(4):486\u201392.","journal-title":"Clin Nutr"},{"issue":"10402","key":"13480_CR65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0140-6736(23)01231-X","volume":"402","author":"A Bhargava","year":"2023","unstructured":"Bhargava A, Bhargava M, Meher A, Benedetti A, Velayutham B, Sai Teja G, Watson B, Barik G, Pathak RR, Prasad R, et al. Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial. Lancet (London England). 2023;402(10402):627\u201340.","journal-title":"Lancet (London England)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13480-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13480-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13480-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:04:24Z","timestamp":1782176664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13480-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13480"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13480-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval was obtained from the Institutional Review Board of Red Cross Hospital of Yulin City, Guangxi, China (Approval No. 2025-K037-01). All participants provided written informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1173"}}